💡 Did you know?
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
History
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
Indraprastha Medical Corporation Limited is an India-based company engaged in the healthcare business. The business activities of the Company are running and operating hospitals, which include Indraprastha Apollo Hospitals and Apollo Hospitals. Indraprastha Apollo Hospitals…
Weekly engine runs — movement reflects the numbers, not analyst opinion.
An exceptional, fast-growing business, fairly priced.
INDRAPRASTHA MEDICAL CORP is scored on the pharma / healthcare framework. It keeps a healthy 12.2% of every rupee of sales as net profit. Cash broadly tracks reported profit (CFO/PAT 0.85×). Free cash flow is worth about 1.5% of its market value.
Over the last 3 years revenue compounded at 11%/yr and profit at 29%/yr. Book value itself has compounded 22%/yr — the hallmark of a genuine compounder. Return on equity is an elite 23.6%. In the latest quarter profit fell 4% versus the prior quarter.
At 19× earnings, the stock sits at the 44th percentile of its own 4.6-year range — the middle of where it has historically traded. Today's price implies ~6%/yr earnings growth for a decade. The books come through clean — a forensic grade of A, and Altman puts distress risk in the safe zone.
A plain-English restatement of the figures on this page — rules-based, for education and research context, not investment advice or a recommendation.
| Ratio | Company | Sector | Read |
|---|---|---|---|
| P/E | 15.76 | 75.46 | better |
| P/B | 3.72 | 3.5 | worse |
| EV/EBITDA | 9.29 | 19.83 | better |
| ROE | 23.59 | — | — |
| ROCE | 31.12 | 10.78 | better |
| ROA | 17.18 | 3.84 | better |
| Quick Ratio | 2.41 | — | — |
| Peer | P/E | P/B | ROE |
|---|---|---|---|
| Apollo Hospitals | 52.0 | 11.4 | 21.1% |
| Max Healthcare | 65.9 | 8.0 | 12.2% |
| Manipal Health Enterprises | 93.9 | 5.2 | 10.6% |
Revenue has grown every year across all 4 financial years shown. 11% CAGR over 3 years — steady double-digit compounder.
Net profit has risen every year — the hallmark of a compounder. Profit is growing faster than revenue (29% vs 11%) — margin expansion is at work.
Operating margin has expanded from 11% to 16% — the business is keeping more of each rupee earned.
ROE at 27% — the business earns well above its cost of equity.
EPS has grown every year — each share earns more than the last, consistently. EPS outpaced profit growth — possible buybacks are concentrating earnings into fewer shares. 37% EPS CAGR — this is the rate at which each share's claim on earnings is compounding.
Operating cash flow has been positive every year — the business generates real cash, not just accounting profit. Heavy investing spend every year, but operations generate enough to cover it — the business self-funds its growth. Financing outflows in consecutive years — balance-sheet discipline through debt repayment or dividends.
When operating cash keeps pace with reported profit, earnings are cash-backed; a persistent shortfall is a quality flag.
Revenue broadly flat QoQ — stable but not accelerating. Run-rate stepping up — recent quarters average 11% above earlier ones.
How today's P/E compares to the stock's own historical range. Dashed line = the 4.6y median.
Promoter holding at 51.0% — majority control intact.
Produced by a rules-based engine over licensed exchange fundamentals — every sentence above is derived from the numbers shown, no analyst or AI opinion involved. Education and research context, not investment advice. We are not SEBI-registered as an Investment Adviser or Research Analyst.